BNP Paribas Financial Markets
BIOA

BNP Paribas Financial Markets’s BioAge Labs BIOA Stock Holding History

BNP Paribas Financial Markets’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
71,487
+39,929
+127% +$721K ﹤0.01% 2906
2026
Q1 		$552K Sell
31,558
-80,231
-72% -$1.55M ﹤0.01% 3529
2025
Q4 		$1.48M Buy
111,789
+86,054
+334% +$763K ﹤0.01% 2847
2025
Q3 		$151K Buy
25,735
+23,800
+1,230% +$111K ﹤0.01% 4129
2025
Q2 		$7.99K Sell
1,935
-52,247
-96% -$211K ﹤0.01% 4903
2025
Q1 		$204K Buy
54,182
+52,057
+2,450% +$241K ﹤0.01% 3682
2024
Q4 		$12.3K Buy
+2,125
New +$36.6K ﹤0.01% 4814

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

BNP Paribas Financial Markets's BIOA Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its BioAge Labs (BIOA) stake by 127% in Q2 2026, buying an estimated $721K and bringing the position to 71,487 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2906.

BNP Paribas Financial Markets first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 139 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • BNP Paribas Financial Markets held 71,487 shares of BioAge Labs worth $1.75M as of Q2 2026.
  • BNP Paribas Financial Markets bought 39,929 BioAge Labs shares in Q2 2026, an estimated $721K.
  • BioAge Labs made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2906 holding.
  • BNP Paribas Financial Markets first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 139 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.